只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-07 2026-07-07 | KYMR Kymera Therapeutics, Inc. | Mainolfi Nello Director,Officer · Chief Executive Officer | 卖出（S） | 50,000 | US$119.00 | US$595万 | 666,568 | SEC |
| 2026-07-01 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Mainolfi Nello Director,Officer · Chief Executive Officer | 卖出（S） | 1,883 | US$112.80 | US$212,411.06 | 744,685 | SEC |
| 2026-07-01 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Mainolfi Nello Director,Officer · Chief Executive Officer | 卖出（S） | 6,626 | US$113.98 | US$755,203.65 | 738,059 | SEC |
| 2026-07-01 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Mainolfi Nello Director,Officer · Chief Executive Officer | 卖出（S） | 24,105 | US$114.96 | US$277.1万 | 713,954 | SEC |
| 2026-07-01 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Mainolfi Nello Director,Officer · Chief Executive Officer | 卖出（S） | 44,050 | US$115.69 | US$509.61万 | 669,904 | SEC |
| 2026-07-01 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Mainolfi Nello Director,Officer · Chief Executive Officer | 卖出（S） | 3,336 | US$116.56 | US$388,840.82 | 666,568 | SEC |
| 2026-07-01 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Goodman Noah Officer · Chief Business Officer | 卖出（S） | 3,389 | US$114.29 | US$387,328.81 | 47,179.438 | SEC |
| 2026-06-30 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Jacobs Bruce N. Officer · Chief Financial Officer | 卖出（S） | 1,500 | US$110.54 | US$165,809.55 | 320,492 | SEC |
| 2026-06-30 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Jacobs Bruce N. Officer · Chief Financial Officer | 卖出（S） | 1,700 | US$111.57 | US$189,664.07 | 318,792 | SEC |
| 2026-06-30 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Jacobs Bruce N. Officer · Chief Financial Officer | 卖出（S） | 1,100 | US$112.79 | US$124,066.91 | 317,692 | SEC |
| 2026-06-30 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Jacobs Bruce N. Officer · Chief Financial Officer | 卖出（S） | 4,110 | US$114.19 | US$469,310.63 | 313,582 | SEC |
| 2026-06-30 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Jacobs Bruce N. Officer · Chief Financial Officer | 卖出（S） | 51,375 | US$114.77 | US$589.63万 | 262,207 | SEC |
| 2026-06-30 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Jacobs Bruce N. Officer · Chief Financial Officer | 卖出（S） | 7,971 | US$115.82 | US$923,178.10 | 254,236 | SEC |
| 2026-06-30 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Jacobs Bruce N. Officer · Chief Financial Officer | 卖出（S） | 6,153 | US$116.99 | US$719,862.24 | 248,083 | SEC |
| 2026-06-30 2026-07-02 | KYMR Kymera Therapeutics, Inc. | Jacobs Bruce N. Officer · Chief Financial Officer | 卖出（S） | 3,200 | US$117.70 | US$376,649.28 | 244,883 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 5,471 | US$105.78 | US$578,722.38 | 2,446,453 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 14,613 | US$106.63 | US$155.82万 | 2,431,840 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 19,093 | US$107.76 | US$205.75万 | 2,412,747 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 848 | US$105.78 | US$89,701.44 | 471,419 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,318 | US$106.63 | US$247,168.34 | 469,101 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 3,024 | US$107.76 | US$325,866.24 | 466,077 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 10,658 | US$108.28 | US$115.4万 | 2,402,089 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 7,833 | US$109.75 | US$859,671.75 | 2,394,256 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 157 | US$111.20 | US$17,458.40 | 461,794 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,199 | US$110.67 | US$132,693.33 | 461,951 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 7,602 | US$110.67 | US$841,313.34 | 2,386,654 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 907 | US$111.20 | US$100,858.40 | 2,385,747 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,688 | US$108.28 | US$182,776.64 | 464,389 | SEC |
| 2026-06-29 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,239 | US$109.75 | US$135,980.25 | 463,150 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 28,296 | US$107.57 | US$304.38万 | 2,834,055 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 231,007 | US$108.14 | US$2498.11万 | 2,603,048 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 32,624 | US$109.79 | US$358.18万 | 2,570,424 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 11,277 | US$110.49 | US$124.6万 | 2,559,147 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 10,366 | US$111.51 | US$115.59万 | 2,548,781 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 555 | US$112.49 | US$62,431.95 | 2,548,226 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 14,913 | US$113.97 | US$169.96万 | 2,533,313 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 27,951 | US$114.94 | US$321.27万 | 2,505,362 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 6,821 | US$115.69 | US$789,121.49 | 2,498,541 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 12,181 | US$117.09 | US$142.63万 | 2,486,360 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 22,046 | US$117.85 | US$259.81万 | 2,464,314 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 12,390 | US$118.66 | US$147.02万 | 2,451,924 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 3,958 | US$107.57 | US$425,762.06 | 525,760 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 32,402 | US$108.14 | US$350.4万 | 493,358 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 4,562 | US$109.79 | US$500,861.98 | 488,796 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,579 | US$110.49 | US$174,463.71 | 487,217 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,442 | US$111.51 | US$160,797.42 | 485,775 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 78 | US$112.49 | US$8,774.22 | 485,697 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,083 | US$113.97 | US$237,399.51 | 483,614 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 3,896 | US$114.94 | US$447,806.24 | 479,718 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 952 | US$115.69 | US$110,136.88 | 478,766 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,701 | US$117.09 | US$199,170.09 | 477,065 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 3,069 | US$117.85 | US$361,681.65 | 473,996 | SEC |
| 2026-06-26 2026-06-30 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,729 | US$118.66 | US$205,163.14 | 472,267 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF Partners OS Ltd. Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | LAMPERT MARK N Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF I GP LLC Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF INC/IL Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF GP HOLDINGS LLC Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF II GP LLC Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF Partners OS Ltd. Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | LAMPERT MARK N Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF I GP LLC Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF INC/IL Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF GP HOLDINGS LLC Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF II GP LLC Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF Partners OS Ltd. Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | LAMPERT MARK N Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF I GP LLC Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF INC/IL Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF GP HOLDINGS LLC Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF II GP LLC Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF Partners OS Ltd. Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF PARTNERS L P/IL Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | LAMPERT MARK N Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF I GP LLC Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF INC/IL Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF GP HOLDINGS LLC Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BVF II GP LLC Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Goodman Noah Officer · Chief Business Officer | 卖出（S） | 2,500 | US$119.00 | US$297,500.00 | 50,195.44 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Goodman Noah Officer · Chief Business Officer | 卖出（S） | 2,500 | US$109.00 | US$272,500.00 | 52,695.44 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 265 | US$110.30 | US$29,229.50 | 593,349 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 86 | US$110.79 | US$9,527.94 | 593,263 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,011 | US$108.83 | US$218,857.13 | 593,614 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 23 | US$108.02 | US$2,484.46 | 595,625 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,399 | US$107.30 | US$150,112.70 | 595,648 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 19,089 | US$118.60 | US$226.4万 | 3,113,085 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 24,268 | US$117.50 | US$285.15万 | 3,132,174 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 81,500 | US$116.53 | US$949.72万 | 3,156,442 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 58,205 | US$115.57 | US$672.68万 | 3,237,942 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 9,229 | US$114.65 | US$105.81万 | 3,296,147 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 10,215 | US$113.70 | US$116.14万 | 3,305,376 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 719 | US$111.89 | US$80,448.91 | 3,315,591 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 614 | US$110.79 | US$68,025.06 | 3,316,310 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,915 | US$110.30 | US$211,224.50 | 3,316,924 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 14,351 | US$108.83 | US$156.18万 | 3,318,839 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 100 | US$111.89 | US$11,189.00 | 593,163 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,437 | US$113.70 | US$163,386.90 | 591,726 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,289 | US$114.65 | US$147,783.85 | 590,437 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 8,389 | US$115.57 | US$969,516.73 | 582,048 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 11,375 | US$116.53 | US$132.55万 | 570,673 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 3,359 | US$117.50 | US$394,682.50 | 567,314 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,646 | US$118.60 | US$313,815.60 | 564,668 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 9,994 | US$107.30 | US$107.24万 | 3,333,349 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 159 | US$108.02 | US$17,175.18 | 3,333,190 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 305 | US$128.69 | US$39,250.45 | 529,764 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 46 | US$129.61 | US$5,962.06 | 529,718 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 37,179 | US$119.71 | US$445.07万 | 3,075,906 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 112,299 | US$120.66 | US$1355万 | 2,963,607 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 40,774 | US$121.38 | US$494.91万 | 2,922,833 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 4,977 | US$122.67 | US$610,528.59 | 2,917,856 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 10,860 | US$123.62 | US$134.25万 | 2,906,996 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 11,711 | US$124.61 | US$145.93万 | 2,895,285 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 3,716 | US$125.82 | US$467,547.12 | 2,891,569 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,609 | US$126.71 | US$203,876.39 | 2,889,960 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 25,075 | US$127.37 | US$319.38万 | 2,864,885 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,197 | US$128.69 | US$282,731.93 | 2,862,688 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 337 | US$129.61 | US$43,678.57 | 2,862,351 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 5,144 | US$119.71 | US$615,788.24 | 559,524 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 15,660 | US$120.66 | US$188.95万 | 543,864 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 5,689 | US$121.38 | US$690,530.82 | 538,175 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 698 | US$122.67 | US$85,623.66 | 537,477 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,517 | US$123.62 | US$187,531.54 | 535,960 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,639 | US$124.61 | US$204,235.79 | 534,321 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 522 | US$125.82 | US$65,678.04 | 533,799 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 223 | US$126.71 | US$28,256.33 | 533,576 | SEC |
| 2026-06-25 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 3,507 | US$127.37 | US$446,686.59 | 530,069 | SEC |
| 2026-06-24 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 103,688 | US$100.42 | US$1041.23万 | 3,357,833 | SEC |
| 2026-06-24 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 14,513 | US$100.42 | US$145.74万 | 599,076 | SEC |
| 2026-06-24 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 14,490 | US$101.14 | US$146.55万 | 3,343,343 | SEC |
| 2026-06-24 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,029 | US$101.14 | US$205,213.06 | 597,047 | SEC |
| 2026-06-23 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,235 | US$99.98 | US$123,475.30 | 3,461,521 | SEC |
| 2026-06-23 2026-06-25 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 173 | US$99.98 | US$17,296.54 | 613,589 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Goodman Noah Officer · Chief Business Officer | 卖出（S） | 2,500 | US$99.00 | US$247,500.00 | 50,195.44 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 14,921 | US$92.14 | US$137.48万 | 3,691,811 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,035 | US$94.48 | US$192,266.80 | 3,689,776 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 11,783 | US$95.12 | US$112.08万 | 3,677,993 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 20,903 | US$96.24 | US$201.17万 | 3,657,090 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 16,084 | US$97.68 | US$157.11万 | 3,641,006 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 25,976 | US$98.58 | US$256.07万 | 3,615,030 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 52,442 | US$99.57 | US$522.16万 | 3,562,588 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 56,348 | US$100.17 | US$564.44万 | 3,506,240 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 6,597 | US$101.61 | US$670,321.17 | 3,499,643 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 8,990 | US$102.48 | US$921,295.20 | 3,490,653 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,179 | US$92.14 | US$200,773.06 | 645,735 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 286 | US$94.48 | US$27,021.28 | 645,449 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,648 | US$95.12 | US$156,757.76 | 643,801 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,919 | US$96.24 | US$280,924.56 | 640,882 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,247 | US$97.68 | US$219,486.96 | 638,635 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 3,603 | US$98.58 | US$355,183.74 | 635,032 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 7,319 | US$99.57 | US$728,752.83 | 627,713 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 7,879 | US$100.17 | US$789,239.43 | 619,834 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 918 | US$101.61 | US$93,277.98 | 618,916 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,253 | US$102.48 | US$128,407.44 | 617,663 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 1,341 | US$104.38 | US$139,973.58 | 613,762 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,560 | US$103.42 | US$264,755.20 | 615,103 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 18,313 | US$103.42 | US$189.39万 | 3,472,340 | SEC |
| 2026-06-22 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 9,584 | US$104.38 | US$100.04万 | 3,462,756 | SEC |
| 2026-06-18 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 5,672 | US$92.16 | US$522,731.52 | 3,706,732 | SEC |
| 2026-06-18 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 32,359 | US$91.85 | US$297.22万 | 3,712,404 | SEC |
| 2026-06-18 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 4,526 | US$91.85 | US$415,713.10 | 648,707 | SEC |
| 2026-06-18 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 793 | US$92.16 | US$73,082.88 | 647,914 | SEC |
| 2026-06-18 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 8,809 | US$90.48 | US$797,038.32 | 653,233 | SEC |
| 2026-06-18 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 62,897 | US$90.48 | US$569.09万 | 3,744,763 | SEC |
| 2026-06-17 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 12,902 | US$90.38 | US$116.61万 | 662,042 | SEC |
| 2026-06-17 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 92,169 | US$90.38 | US$833.02万 | 3,807,660 | SEC |
| 2026-06-17 2026-06-22 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 11,741 | US$89.98 | US$105.65万 | 0 | SEC |
| 2026-05-27 2026-05-27 | KYMR Kymera Therapeutics, Inc. | Chadwick Jeremy G Officer · Chief Operating Officer | 卖出（S） | 600 | US$82.08 | US$49,248.00 | 44,018 | SEC |
| 2026-05-27 2026-05-27 | KYMR Kymera Therapeutics, Inc. | Chadwick Jeremy G Officer · Chief Operating Officer | 卖出（S） | 3,679 | US$81.50 | US$299,838.50 | 44,618 | SEC |
| 2026-05-26 2026-05-27 | KYMR Kymera Therapeutics, Inc. | Chadwick Jeremy G Officer · Chief Operating Officer | 卖出（S） | 3,730 | US$78.36 | US$292,282.80 | 57,472 | SEC |
| 2026-05-26 2026-05-27 | KYMR Kymera Therapeutics, Inc. | Chadwick Jeremy G Officer · Chief Operating Officer | 卖出（S） | 324 | US$79.17 | US$25,651.08 | 57,148 | SEC |
| 2026-05-26 2026-05-27 | KYMR Kymera Therapeutics, Inc. | Chadwick Jeremy G Officer · Chief Operating Officer | 卖出（S） | 3,800 | US$79.39 | US$301,682.00 | 53,348 | SEC |
| 2026-05-26 2026-05-27 | KYMR Kymera Therapeutics, Inc. | Chadwick Jeremy G Officer · Chief Operating Officer | 卖出（S） | 551 | US$80.71 | US$44,471.21 | 48,297 | SEC |
| 2026-05-26 2026-05-27 | KYMR Kymera Therapeutics, Inc. | Chadwick Jeremy G Officer · Chief Operating Officer | 卖出（S） | 4,500 | US$80.02 | US$360,090.00 | 48,848 | SEC |
| 2026-05-11 2026-05-11 | KYMR Kymera Therapeutics, Inc. | Ridloff Elena Director | 卖出（S） | 3,000 | US$87.00 | US$261,000.00 | 0 | SEC |
| 2026-04-29 2026-04-29 | KYMR Kymera Therapeutics, Inc. | Mainolfi Nello Director,Officer · Chief Executive Officer | 卖出（S） | 936 | US$82.45 | US$77,173.20 | 666,195 | SEC |
| 2026-04-29 2026-04-29 | KYMR Kymera Therapeutics, Inc. | Mainolfi Nello Director,Officer · Chief Executive Officer | 卖出（S） | 17,005 | US$80.74 | US$137.3万 | 679,190 | SEC |
| 2026-04-29 2026-04-29 | KYMR Kymera Therapeutics, Inc. | Mainolfi Nello Director,Officer · Chief Executive Officer | 卖出（S） | 12,059 | US$81.70 | US$985,220.30 | 667,131 | SEC |
| 2026-04-22 2026-04-24 | KYMR Kymera Therapeutics, Inc. | Chadwick Jeremy G Officer · Chief Operating Officer | 卖出（S） | 300 | US$90.00 | US$27,000.00 | 61,202 | SEC |
| 2026-04-22 2026-04-24 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 88 | US$90.08 | US$7,927.04 | 3,899,829 | SEC |
| 2026-04-22 2026-04-24 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 5,900 | US$89.96 | US$530,764.00 | 0 | SEC |
| 2026-04-22 2026-04-24 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 12 | US$90.08 | US$1,080.96 | 674,944 | SEC |
| 2026-04-15 2026-04-16 | KYMR Kymera Therapeutics, Inc. | Chadwick Jeremy G Officer · Chief Operating Officer | 卖出（S） | 1,300 | US$90.00 | US$117,000.00 | 61,202 | SEC |
| 2026-04-15 2026-04-16 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,200 | US$89.95 | US$197,890.00 | 0 | SEC |
| 2026-04-15 2026-04-16 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 2,750 | US$90.10 | US$247,775.00 | 3,899,917 | SEC |
| 2026-04-15 2026-04-16 | KYMR Kymera Therapeutics, Inc. | Booth Bruce Director | 卖出（S） | 385 | US$90.10 | US$34,688.50 | 674,956 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| KYMR | 149,237.3925 | 0 | 202,794.4662 | 73.59% | B, Q, N |